Foghorn Therapeutics Inc. (FHTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

AppLovin, Silvercorp Metals and Powell Industries have been selected as the top picks with a high net income ratio.

Zentalis Pharmaceuticals, Inc. (ZNTL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful ...

In a report released yesterday, Jonathan Koh from UOB Kay Hian maintained a Buy rating on Digital Core REIT (DCRU – Research Report), with a ...

As we enter 2025, many growth stocks are trading at high valuations and could be running out of room to rise in the near term ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Under Armour, Inc. (UAA Quick Quote UAA - Free Report) : This performance apparel, footwear, and accessories company has seen ...

Growth stocks are equity shares likely to outperform their peers and the broader market. Here's a list of stocks that contain investment potential to beef up your portfolio.

Needham analyst Ami Fadia maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) today and set a price target of $133.00.Don't ...

Vanguard International High Dividend Yield Index Fund offers global diversification and strong dividend income potential.